Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Pfizer, Inc.
(NY:
PFE
)
29.10
USD
-0.30 (-1.02%)
Official Closing Price
/ Updated:
6:40 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Pfizer, Inc.
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
StreetInsider.com After-Hours Movers 6/19: (FNSR) (BEAT) (JDSU) Higher; (FIVE) (MU) (JBL) Lower (more...)
June 19, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8432959 for the full story.
Read More
from
StreetInsider.com News Articles
UPDATE: Pfizer Reports Final Exchange Ratio of 0.9898 for Zoetis Exchange Offer, Extends Offer to Jun. 21st
June 19, 2013
Pfizer Inc. (NYSE: PFE ) today announced the final exchange ratio in connection with its previously announced offer to its shareholders to exchange some or all of their shares of Pfizer common stock...
Read More
category
ZTS
,
Benzinga
,
News
, and 1 more.
from
Latest Articles from Benzinga.com
Final Conversion Ratio Offered by Pfizer (PFE) for Zoetis (ZTS) Shares is 0.9898
June 19, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8432477 for the full story.
Read More
from
StreetInsider.com News Articles
Watch for Shares of Pfizer (PFE) to Approach Resistance at $29.71
June 19, 2013
from
Comtex SmarTrend® News Briefs
BMO Says Pfizer, Zoetis Exchange Offer Looking More Attractive, Sees Bid at High End of Ratio
June 19, 2013
With traders waiting on the ratio for the Pfizer (NYSE: PFE ) and Zoetis (NYSE: ZTS ) exchange offer (expected for after the close Wednesday), BMO's Alex Arfaei is commenting. The analyst beileves the...
Read More
category
ZTS
,
Benzinga
,
Analyst Ratings
, and 2 more.
from
Latest Articles from Benzinga.com
Interesting Similarities Among 2013's Top-Performing ETFs
June 18, 2013
With 2013 nearly half complete, now is a good time to look at this year's top-performing ETFs to see what has worked, what might keep working and which funds could be vulnerable to second-half...
Read More
category
Specialty ETFs
,
Benzinga
,
PBE
, and 24 more.
from
Latest Articles from Benzinga.com
Tuesday's ETF with Unusual Volume: IWX
June 18, 2013
The iShares Russell Top 200 Value Index Fund (IWX) is seeing unusually high volume in afternoon trading Tuesday, with over 207,000 shares traded versus three month average volume of about 41,000....
Read More
category
ETFs
from
ETF Channel
The NIH Aims To Develop Drugs That Big Pharma Discarded
June 18, 2013
This morning, the National Institutes of Health awarded $12.7 million to nine academic groups to test potential medicines for diseases including Alzheimer's disease, Duchenne muscular dystrophy, and...
Read More
category
NYSE:JNJ
,
NASDAQ:CBST
,
NYSE:PFE
, and 2 more.
from
Forbes Real Time
Supreme Court Permits Antitrust Scrutiny Of Pharma Settlements
June 18, 2013
In a ruling that is likely to have a far-reaching impact on the pharmaceutical industry, the Supreme Court permitted antitrust scrutiny of reverse pay settlements used between brand name drug makers...
Read More
category
NYSE:MRK
,
NYSE:PFE
,
NYSE:BMY
, and 1 more.
from
Forbes Real Time
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market
June 18, 2013
category
Pharmaceuticals
from
Trefis
Court Appoints Lead Plaintiff in Shareholder Lawsuit Against SAC
June 17, 2013
A New York court designated a pension fund as the lead plaintiff in a lawsuit filed by shareholders of Elan against SAC Capital.
Read More
from
FOX News
Court appoints lead plaintiff in shareholder lawsuit against SAC
June 17, 2013
June 18 (Reuters) - A New York court designated a pension fund as the lead plaintiff in a lawsuit filed by shareholders of Elan Corp against SAC Capital, a court filing showed, as the hedge fund...
Read More
category
companyNews
from
Reuters: Company News
pSivida stock rises after being named as a takeover target
June 17, 2013
Stock in pSivida Corp. (Nasdaq: PSDV) rose 9 percent Monday after its treatment for some types of chronic diabetic macular edema (DME) was deemed cost effective by a UK agency, and the company was...
Read More
category
Paul Ashton
,
Watertown
,
Biotech
, and 6 more.
from
Business Journals
Supreme Court Ruling Creates Uncertainly for Drug Makers (ACT) (MYL) (MRK)
June 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8422776 for the full story.
Read More
from
StreetInsider.com News Articles
Datawatch to buy Swedish software biz, ‘cool vendor’ in deal worth $31.4M
June 17, 2013
Building on its strategy to boost partnerships and securing deals with more than 18 new partners this year, Datawatch Corp...
Read More
category
Gartner Inc/
,
Citigroup
,
Michael Morrison
, and 7 more.
from
Business Journals
BCG Weighs In On First-In-Class Vs. Best-In-Class Drugs -- How Valuable Is Their Advice?
June 17, 2013
The hardest decisions facing a head of a pharmaceutical R&D organization involve determining which great ideas to fund. One might think this is a simple process, that any idea which can lead to a new...
Read More
category
NYSE:PFE
,
NYSE:BMY
from
Forbes Real Time
Pfizer - Roundup Review
June 17, 2013
NEW YORK (AVAFIN) -- Block trades serve as a useful indicator for investors trying ...
Read More
from
AVAFIN
UK scientists win funding for new kind of anticoagulant drug
June 16, 2013
LONDON, June 17 (Reuters) - British scientists have won early financial backing for a new kind of anticoagulant drug they believe may prevent dangerous blood clots without causing bleeding - a...
Read More
category
companyNews
from
Reuters: Company News
Friday's ETF with Unusual Volume: XPH
June 14, 2013
The SPDR S&P Pharmaceuticals ETF (XPH) is seeing unusually high volume in afternoon trading Friday, with over 119,000 shares traded versus three month average volume of about 40,000. Shares of XPH were...
Read More
category
ETFs
from
ETF Channel
BioLabs' shareholder questions ROI
June 14, 2013
Jeffrey Chokel, a longtime Cleveland BioLabs Inc. shareholder from Shaker Heights, Ohio, cut right to the chase at the company’s annual shareholder meeting Friday morning...
Read More
category
Cleveland BioLabs Inc/
,
Julia Brown
,
David Hohn
, and 11 more.
from
Business Journals
For Love and Money: Three Growth Stocks from Casey’s Alex Daley
June 13, 2013
category
Pharmaceuticals
,
Medical Devices & Supplies
from
Trefis
Streetinsider.com's Hot Lunchtime Reads 06/13: (MYGN) (CLSN) (DOLE) (PFE)
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8414612 for the full story.
Read More
from
StreetInsider.com News Articles
Pfizer's (PFE) Germano: Company Still in 'Evaluation Process' on Possible Split
June 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8414513 for the full story.
Read More
from
StreetInsider.com News Articles
Wall Street Fundamentals Releases New In-Depth Stock Reports on AXP, BIIB, PGE, TGT
June 13, 2013
from
ACCESSWIRE
VTV, GE, PFE, T: Large Inflows Detected at ETF
June 13, 2013
Symbols mentioned in this story: VTV, GE, PFE, T Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units'' can...
Read More
category
ETFs
from
ETF Channel
Microsoft Corporation Becomes #24 Most Shorted Dow Stock, Replacing Pfizer Inc
June 13, 2013
The most recent short interest data has been released by the NASDAQ for the 05/15/2013 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying...
Read More
category
Stocks
from
Market News Video
Verastem directors buy $475K of stock, company set for potential pivotal trials
June 13, 2013
Three directors of cancer drug company Verastem Inc. and its founding executive chairman have purchased $475,000 worth of the company’s stock in the past week as it plans to start a potential pivotal...
Read More
category
Genzyme Corp/
,
U/S/ Food and Drug Administration
,
John Clarke
, and 10 more.
from
Business Journals
INSIGHT-No smoke, plenty of fire fuels e-cigarettes
June 13, 2013
* E-cigarettes sold as less harmful alternative to tobacco
Read More
category
companyNews
from
Reuters: Company News
PRESS DIGEST - Wall Street Journal - June 13
June 13, 2013
June 13 (Reuters) - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.
Read More
category
companyNews
from
Reuters: Company News
Biotech Value Investments For 2013 With No Approval Risk
June 12, 2013
category
Pharmaceuticals
from
Trefis
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here